LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 24 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,719,000 | -2.4% | 10,000,000 | 0.0% | 0.12% | -15.0% |
| Q4 2021 | $9,956,000 | -0.6% | 10,000,000 | 0.0% | 0.15% | +2.8% |
| Q3 2021 | $10,017,000 | -18.9% | 10,000,000 | -20.0% | 0.14% | +49.0% |
| Q2 2021 | $12,354,000 | -4.5% | 12,500,000 | 0.0% | 0.10% | -25.6% |
| Q1 2021 | $12,938,000 | -38.9% | 12,500,000 | -44.4% | 0.13% | -48.0% |
| Q4 2020 | $21,172,000 | +4.3% | 22,500,000 | 0.0% | 0.25% | -14.2% |
| Q3 2020 | $20,292,000 | +2.8% | 22,500,000 | 0.0% | 0.29% | -39.4% |
| Q2 2020 | $19,733,000 | +6.2% | 22,500,000 | 0.0% | 0.48% | -3.8% |
| Q1 2020 | $18,577,000 | -4.3% | 22,500,000 | 0.0% | 0.50% | +13.5% |
| Q4 2019 | $19,418,000 | +3.5% | 22,500,000 | 0.0% | 0.44% | +18.8% |
| Q3 2019 | $18,753,000 | -3.5% | 22,500,000 | 0.0% | 0.37% | +74.4% |
| Q2 2019 | $19,426,000 | – | 22,500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |